 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||
15 December 1994 | Volume 121 Issue 12 | Pages 953-959
The complexities of the chronic fatigue syndrome and the methodologic problems associated with its study indicate the need for a comprehensive, systematic, and integrated approach to the evaluation, classification, and study of persons with this condition and other fatiguing illnesses.We propose a conceptual framework and a set of guidelines that provide such an approach. Our guidelines include recommendations for the clinical evaluation of fatigued persons, a revised case definition of the chronic fatigue syndrome, and a strategy for subgrouping fatigued persons in formal investigations.
*For a listing of members of the Study Group, see Appendix.
Issues in Chronic Fatigue Syndrome Research
The central issue in chronic fatigue syndrome research is whether the chronic fatigue syndrome or any subset of it is a pathologically discrete entity, as opposed to a debilitating but nonspecific condition shared by many different entities. Resolution of this issue depends on whether clinical, epidemiologic, and pathophysiologic features convincingly distinguish the chronic fatigue syndrome from other illnesses.
Clarification of the relation between the chronic fatigue syndrome and the neuropsychiatric syndromes is particularly important. The latter disorders are potentially the most important source of confounding in studies of chronic fatigue syndrome. Somatoform disorders, anxiety disorders, major depression, and other symptomatically defined syndromes can manifest severe fatigue and several somatic and psychological symptoms and are diagnosed more frequently in populations affected by chronic fatigue [11-13] and the chronic fatigue syndrome [14, 15] than in the general population.
The extent to which the features of the chronic fatigue syndrome are generic features of chronic fatigue and deconditioning due to physical inactivity common to a diverse group of illnesses [16, 17] must also be established.
A Conceptual Framework for Studying the Chronic Fatigue Syndrome
In the United States, 24% of the general adult population has had fatigue lasting 2 weeks or longer; 59% to 64% of these persons report that their fatigue has no medical cause [18, 19]. In one study, 24% of patients in primary care clinics reported having had prolonged fatigue (
We propose a conceptual framework Figure 1 to guide the development of studies relevant to the chronic fatigue syndrome. In this framework, in which the chronic fatigue syndrome is considered a subset of prolonged fatigue (DIAGNOSIS AND TREATMENT
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
We have developed a conceptual framework and a set of research guidelines for use in studies of the chronic fatigue syndrome. The guidelines cover the clinical and laboratory evaluation of persons with unexplained fatigue; the identification of underlying conditions that may explain the presence of chronic fatigue; revised criteria for defining cases of the chronic fatigue syndrome; and a strategy for dividing the chronic fatigue syndrome and other unexplained cases of chronic fatigue into subgroups.
Background
The chronic fatigue syndrome is a clinically defined condition [1-4] characterized by severe disabling fatigue and a combination of symptoms that prominently features self-reported impairments in concentration and short-term memory, sleep disturbances, and musculoskeletal pain. Diagnosis of the chronic fatigue syndrome can be made only after alternative medical and psychiatric causes of chronic fatiguing illness have been excluded. No pathognomonic signs or diagnostic tests for this condition have been validated in scientific studies [5-7]; moreover, no definitive treatments for it exist [8]. Recent longitudinal studies suggest that some persons affected by the chronic fatigue syndrome improve with time but that most remain functionally impaired for several years [9, 10]. 
1 month) [20]. In many persons with prolonged fatigue, fatigue persists beyond 6 months (defined as chronic fatigue) [21, 22]. 1 month), epidemiologic studies of populations defined by prolonged or chronic fatigue can be used to search for illness patterns consistent with the chronic fatigue syndrome. Such studies, which differ from case–control and cohort studies based on predetermined criteria for the chronic fatigue syndrome, will also produce much-needed clinical and laboratory background information.
|
This framework also clarifies the need to compare populations defined by the chronic fatigue syndrome with several other populations in case–control and cohort studies. The most important comparison populations are those defined by overlapping disorders, by prolonged fatigue, and by forms of chronic fatigue that do not meet criteria for the chronic fatigue syndrome. Controls drawn exclusively from healthy populations are inadequate to confirm the specificity of chronic fatigue syndrome-associated abnormalities.
Need for Revised Criteria To Define the Chronic Fatigue Syndrome
The possibility that chronic fatigue syndrome study populations have been selected or defined in substantially different ways has made it difficult to interpret conflicting laboratory findings related to the chronic fatigue syndrome [23]. For example, the North American chronic fatigue syndrome working case definition [1] has been inconsistently applied by researchers [24]. This case definition is frequently modified in practice because some of the criteria are difficult to interpret or to comply with [25] and because opinions differ about the classification of chronic fatigue cases preceded by a history of psychiatric illnesses [26, 27].
Current criteria for the chronic fatigue syndrome also do not appear to define a distinct group of cases (28; Reyes M, et al. Unpublished data). For example, participants in the Centers for Disease Control and Prevention (CDC) chronic fatigue syndrome surveillance system [29] who met the chronic fatigue syndrome case definition did not substantially differ by demographic characteristics, symptoms, and other illness features from those who did not meet the definition (except by criteria used to place patients into one of our predetermined surveillance classification categories [Reyes M, et al. Unpublished data]). These findings indicate that additional subgrouping or stratification of study cases into more homogeneous groups is necessary for comparative studies.
Need for Clinical Evaluation Standards
Our experience suggests that fatigued persons often receive either inadequate or excessive medical evaluations. In the CDC chronic fatigue syndrome surveillance system, all participants were clinically evaluated by a primary physician before enrollment. Subsequently, 18% were found to have a preexisting medical condition that plausibly accounted for their chronic fatiguing illness (Reyes M, et al. Unpublished data). These medical conditions were identified either from a single battery of routine laboratory tests done on blood specimens obtained at enrollment or from review of available medical records.
We believe that inappropriate tests are often used to diagnose the chronic fatigue syndrome in chronically fatigued persons. This practice should be discouraged.
Need for a Comprehensive and Integrated Approach
The complexities of the chronic fatigue syndrome and the existence of several obstacles to our understanding of it make a comprehensive and integrated approach to the study of the chronic fatigue syndrome and similar illnesses desirable. The purpose of the following proposed guidelines Figure 2 is to facilitate such an approach.
|
Guidelines for the Clinical Evaluation and Study of the Chronic Fatigue Syndrome and Other Illnesses Associated with Unexplained Chronic Fatigue
|
|---|
Prolonged fatigue is defined as self-reported, persistent fatigue lasting 1 month or longer. Chronic fatigue is defined as self-reported persistent or relapsing fatigue lasting 6 or more consecutive months.
The presence of prolonged or chronic fatigue requires clinical evaluation to identify underlying or contributing conditions that require treatment. Further diagnosis or classification of chronic fatigue cases cannot be made without such an evaluation. The following items should be included in the clinical evaluation.
1. A thorough history that covers medical and psychosocial circumstances at the onset of fatigue; depression or other psychiatric disorders; episodes of medically unexplained symptoms; alcohol or other substance abuse; and current use of prescription and over-the-counter medications and food supplements.
2. A mental status examination to identify abnormalities in mood, intellectual function, memory, and personality. Particular attention should be directed toward current symptoms of depression or anxiety, self-destructive thoughts, and observable signs such as psychomotor retardation. Evidence of a psychiatric or neurologic disorder requires that an appropriate psychiatric, psychological, or neurologic evaluation be done.
3. A thorough physical examination.
4. A minimum battery of laboratory screening tests including complete blood count with leukocyte differential; erythrocyte sedimentation rate; serum levels of alanine aminotransferase, total protein, albumin, globulin, alkaline phosphatase, calcium, phosphorus, glucose, blood urea nitrogen, electrolytes, and creatinine; determination of thyroid-stimulating hormone; and urinalysis.
Routinely doing other screening tests for all patients has no known value [20, 30]. However, further tests may be indicated on an individual basis to confirm or exclude another diagnosis, such as multiple sclerosis. In these cases, additional tests or procedures should be done according to accepted clinical standards.
The use of tests to diagnose the chronic fatigue syndrome (rather than to exclude other diagnostic possibilities) should be done only in the setting of protocol-based research. The fact that such tests are investigational and do not aid in diagnosis or management should be explained to the patient.
In clinical practice, no additional tests, including laboratory tests and neuroimaging studies, can be recommended for the specific purpose of diagnosing the chronic fatigue syndrome. Tests should be directed toward confirming or excluding other etiologic possibilities. Examples of specific tests that do not confirm or exclude the diagnosis of the chronic fatigue syndrome include serologic tests for Epstein-Barr virus, retroviruses, human herpesvirus 6, enteroviruses, and Candida albicans; tests of immunologic function, including cell population and function studies; and imaging studies, including magnetic resonance imaging scans and radionuclide scans (such as single-photon emission computed tomography and posi-tron emission tomography) of the head.
Conditions That Explain Chronic Fatigue
The following conditions exclude a patient from the diagnosis of unexplained chronic fatigue.
1. Any active medical condition that may explain the presence of chronic fatigue [31], such as untreated hypothyroidism, sleep apnea, and narcolepsy, and iatrogenic conditions such as side effects of medication.
2. Any previously diagnosed medical condition whose resolution has not been documented beyond reasonable clinical doubt and whose continued activity may explain the chronic fatiguing illness. Such conditions may include previously treated malignancies and unresolved cases of hepatitis B or C virus infection.
3. Any past or current diagnosis of a major depressive disorder with psychotic or melancholic features; bipolar affective disorders; schizophrenia of any subtype; delusional disorders of any subtype; dementias of any subtype; anorexia nervosa; or bulimia nervosa.
4. Alcohol or other substance abuse within 2 years before the onset of the chronic fatigue and at any time afterward.
5. Severe obesity [32, 33] as defined by a body mass index (body mass index = weight in kilograms/[height in meters]2) 45.
Any unexplained physical examination finding or laboratory or imaging test abnormality that strongly suggests the presence of an exclusionary condition must be resolved before further classification.
Conditions That Do Not Adequately Explain Chronic Fatigue
The following conditions do not exclude a patient from the diagnosis of unexplained chronic fatigue.
1. Any condition defined primarily by symptoms that cannot be confirmed by diagnostic laboratory tests, including fibromyalgia, anxiety disorders, somatoform disorders, nonpsychotic or nonmelancholic depression, neurasthenia, and multiple chemical sensitivity disorder.
2. Any condition under specific treatment sufficient to alleviate all symptoms related to that condition and for which the adequacy of treatment has been documented. Such conditions include hypothyroidism for which the adequacy of replacement hormone has been verified by normal thyroid-stimulating hormone levels or asthma in which the adequacy of treatment has been determined by pulmonary function and other testing.
3. Any condition, such as Lyme disease or syphilis, that was treated with definitive therapy before development of chronic symptomatic sequelae.
4. Any isolated and unexplained physical examination finding or laboratory or imaging test abnormality that is insufficient to strongly suggest the existence of an exclusionary condition. Such conditions include an elevated antinuclear antibody titer that is inadequate to strongly support a diagnosis of a discrete connective tissue disorder without other laboratory or clinical evidence.
Major Classification Categories: Chronic Fatigue Syndrome and Idiopathic Chronic Fatigue
Clinically evaluated, unexplained cases of chronic fatigue can be separated into either the chronic fatigue syndrome or idiopathic chronic fatigue on the basis of the following criteria.
A case of the chronic fatigue syndrome is defined by the presence of the following: 1) clinically evaluated, unexplained, persistent or relapsing chronic fatigue that is of new or definite onset [has not been lifelong]; is not the result of ongoing exertion; is not substantially alleviated by rest; and results in substantial reduction in previous levels of occupational, educational, social, or personal activities; and 2) the concurrent occurrence of four or more of the following symptoms, all of which must have persisted or recurred during 6 or more consecutive months of illness and must not have predated the fatigue: self-reported impairment in short-term memory or concentration severe enough to cause substantial reduction in previous levels of occupational, educational, social, or personal activities; sore throat; tender cervical or axillary lymph nodes; muscle pain, multijoint pain without joint swelling or redness; headaches of a new type, pattern, or severity; unrefreshing sleep; and postexertional malaise lasting more than 24 hours.
The method used (for example, a predetermined checklist developed by the investigator or spontaneous reporting by the study participant) to establish the presence of these and any other symptoms should be specified.
A case of idiopathic chronic fatigue is defined as clinically evaluated, unexplained chronic fatigue that fails to meet criteria for the chronic fatigue syndrome. The reasons for failing to meet the criteria should be specified.
Subgrouping and Stratification of Major Classification Categories
In formal studies, cases of the chronic fatigue syndrome and idiopathic chronic fatigue should be subgrouped before analysis or stratified during analysis by the presence or absence of essential variables, which should be routinely established in all studies. Further subgrouping by optional variables can be done according to specific research interests.
Essential Subgrouping Variables
1. Any clinically important coexisting medical or neuropsychiatric condition that does not explain the chronic fatigue. The presence or absence, classification, and timing of onset of neuropsychiatric conditions should be established using published or freely available instruments, such as the Composite International Diagnostic Instrument [34], the National Institute of Mental Health Diagnostic Interview Schedule [35], and the Structured Clinical Interview for DSM-III(R) [36].
2. Current level of fatigue, including subjective or performance aspects. These levels should be measured using published or widely available instruments. Examples include instruments by Schwartz and colleagues [37], Piper and colleagues [38], Krupp and colleagues [39], Chalder and colleagues [40], and Vercoulen and colleagues [41].
3. Total duration of fatigue.
4. Current level of overall functional performance as measured by published or widely available instruments, such as the Medical Outcomes Study Short Form 36 [42] and the Sickness Impact Profile [43].
Optional Subgrouping Variables
Examples of optional variables include: 1. Epidemiologic or laboratory features of specific interest to researchers. Examples include laboratory documentation or self-reported history of an infectious illness at the onset of fatiguing illness, a history of rapid onset of illness, or the presence or level of a particular immunologic marker.
2. Measurements of physical function quantified by means such as treadmill testing or motion-sensing devices.
Discussion
|
|---|
 Top Discussion Author & Article InfoReferences |
|---|
Several specific points about the clinical evaluation are worth emphasizing. The primary purpose of clinically evaluating a person with unexplained fatigue is to identify and treat any underlying and contributing factors. Such an evaluation should begin, whenever possible, before 6 months have elapsed. Because the particulars of any clinical evaluation will vary from patient to patient, our recommendations have been limited to those aspects of clinical evaluation that can be universally applied to all patients. With regard to the clinical psychiatric evaluation of fatigued persons, we consider a mental status examination to be the minimal acceptable level of assessment. Although a structured psychiatric evaluation of all patients with fatigue is highly desirable, we recognize the practical difficulties of implementing such a recommendation. Diagnosis of the chronic fatigue syndrome should not impede the treatment of coexisting disorders, notably depression.
Many conditions that are primary causes of chronic fatigue preclude the diagnosis of the chronic fatigue syndrome or idiopathic chronic fatigue. We presented principles for identifying such exclusionary conditions rather than listing them because of the range and complexity of human illnesses. In some instances, however, we identified specific exclusionary conditions. The presence of severe obesity makes the diagnosis of unexplained symptoms, such as fatigue or joint pains, extremely difficult. We distinguished between psychiatric conditions for pragmatic reasons. It is difficult to interpret symptoms typical of the chronic fatigue syndrome in the setting of illnesses such as major psychotic depression or schizophrenia. More importantly, care of these persons should focus on their chronic psychiatric disorder. On the other hand, we did not use other psychiatric disorders, such as anxiety disorders and less severe forms of depression, as a basis for exclusion. Such psychiatric conditions are highly prevalent in persons with chronic fatigue and the chronic fatigue syndrome, and the exclusion of persons with these conditions would substantially hinder efforts to clarify the role that psychiatric disorders have in fatiguing illnesses. This is a particularly important issue to resolve. These parts of the guidelines concur with the recommendation by a 1991 National Institutes of Health workshop [24] that chronic fatigue cases preceded by some, but not all, psychiatric syndromes can be classified as the chronic fatigue syndrome.
The revised case definition for the chronic fatigue syndrome is modeled on the 1988 chronic fatigue syndrome working case definition [1]. The purpose of our revisions was to address some of the criticisms [25] of that case definition and to facilitate a more systematic collection of data internationally. We dropped all physical signs from our inclusion criteria because we agreed that their presence had been unreliably documented in past studies. The required number of symptoms was decreased from 8 to 4 and the list of symptoms was decreased from 11 to 8 because we agreed that multiple symptom criteria had increased the restrictiveness of the 1988 chronic fatigue syndrome working case definition without increasing the homogeneity of cases (Reyes M, et al. Unpublished data). Whether to retain any symptom criteria other than chronic fatigue generated the most disagreement among the authors. Disagreement occurred between those who favored a more restrictive approach (using several symptom criteria), as was done in the 1988 chronic fatigue syndrome working case definition, and those who favored a broader definition of chronic fatigue syndrome (using fewer symptom criteria) as was done in the Australian [3] and British [4] chronic fatigue syndrome case definitions. Those favoring multiple symptoms argued that use of multiple symptoms best reflected the empiric clinical sense of the chronic fatigue syndrome as a distinct entity. Others argued that no symptoms have been shown to be specific for the chronic fatigue syndrome [28] and that some studies suggest that a requirement for multiple symptoms biases the selection of cases toward those with psychiatric disorders [28, 44]. Disagreement over this particular issue underscores the need to establish specific features of the chronic fatigue syndrome and the validity of any chronic fatigue syndrome case definition.
Developing an operational definition of fatigue was a problem because the concept of fatigue itself is unclear [45, 46]. In our conception of the chronic fatigue syndrome, the symptom of fatigue refers to severe mental and physical exhaustion, which differs from somnolence or lack of motivation and which is not attributable to exertion or diagnosable disease. We retained the requirement of 6 months' duration of fatigue to facilitate comparison with earlier cases of the chronic fatigue syndrome. The requirement for an "average daily activity below 50%" was eliminated because this level of impairment is difficult to verify.
We defined the condition of "idiopathic chronic fatigue" to focus attention on the need to clarify how other forms of unexplained chronic fatigue are related to the chronic fatigue syndrome.
Our strategy for subgrouping major classification categories depends on the data made available from standardized evaluations of patients with chronic fatigue. Subgrouping by essential variables will encourage the collection of a body of core data. Additional subgrouping by optional variables will allow researchers considerable flexibility in defining specific subgroups to answer specific research questions.
The name "chronic fatigue syndrome" is the final issue that we wish to address. We sympathize with those who are concerned that this name may trivialize this illness. The impairments associated with chronic fatigue syndrome are not trivial. However, we believe that changing the name without adequate scientific justification will lead to confusion and will substantially undermine the progress that has been made in focusing public, clinical, and research attention on this illness. We support changing the name when more is known about the underlying pathophysiologic process or processes associated with the chronic fatigue syndrome and chronic fatigue.
Appendix
|
|---|
Author and Article Information
|
|---|
|
TopDiscussionAuthor & Article InfoReferences |
|---|
References
|
|---|
|
TopDiscussionAuthor & Article InfoReferences |
|---|
1. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988; 108:387-9.
2. Lloyd AR, Wakefield D, Boughton C, Dwyer J. What is myalgic encephalomyelitis? (Letter). Lancet. 1988; 1:1286-7.
3. Lloyd AR, Hickie I, Boughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust. 1990; 153:522-8.
4. Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991; 84:118-21.
5. Holmes GP. The chronic fatigue syndrome. In: Schlossberg D, ed. Infectious Mononucleosis. 2nd ed. New York: Springer-Verlag; 1989:172-93.
6. Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis. 1992; 15:812-23.
7. Shafran SD. The chronic fatigue syndrome. Am J Med. 1991; 90:730-9.
8. Wilson A, Hickie I, Lloyd A, Wakefield D. The treatment of chronic fatigue syndrome: science and speculation. Am J Med. 1994; 96:544-50.
9. Wilson A, Hickie I, Lloyd A, Hadzi-Pavlovic D, Boughton C, Dwyer J, et al. Longitudinal study of outcome of chronic fatigue syndrome. BMJ. 1994; 308:756-9.
10. Peterson PK, Schenck CH, Sherman R. Chronic fatigue syndrome in Minnesota. Minn Med. 1991; 74:21-6.
11. Manu P, Matthews DA, Lane TJ. The mental health of patients with a chief complaint of chronic fatigue. A prospective evaluation and follow-up. Arch Intern Med. 1988; 148:2213-7.
12. Manu P, Matthews DA, Lane TJ. Panic disorder among patients with chronic fatigue. South Med J 1991; 84:451-6.
13. Manu P, Lane TJ, Matthews DA. Somatization disorder in patients with chronic fatigue. Psychosomatics. 1989; 30:388-95.
14. Kruesi MJ, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry. 1989; 50:53-6.
15. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic postviral fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry. 1989; 52:940-8.
16. Swartz MN. The chronic fatigue syndrome—one entity or many? N Engl J Med. 1988; 319:1726-8.
17. Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJ, Wessely SC. Population based study of fatigue and psychological distress. BMJ. 1994; 308:763-6.
18. Price RK, North CS, Wessely S, Fraser VJ. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep. 1992; 107:514-22.
19. Walker EA, Katon WJ, Jemelka RP. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med. 1993; 8:436-40.
20. Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA. 1988; 206:929-34.
21. Sharpe M, Hawton K, Seagroatt V, Pasvol G. Follow up of patients presenting with fatigue to an infectious diseases clinic. BMJ. 1992; 305:147-52.
22. Bates DW, Schmitt W, Buchwald D, Ware NC, Lee J, Thoyer E, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med. 1993; 153:2759-65.
23. Mawle AC, Reyes M, Schmid DS. Is chronic fatigue syndrome an infectious disease? Infect Agents Dis. 1994; 2:333-41.
24. Schluederberg A, Straus SE, Peterson P, Blumenthal S, Komaroff AL, Spring SB, et al. NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med. 1992; 117:325-31.
25. Straus SE. Defining the chronic fatigue syndrome (Editorial). Arch Intern Med. 1992; 152:1569-70.
26. Matthews DA, Lane TJ, Manu P. Definition of the chronic fatigue syndrome (Letter). Ann Intern Med. 1988; 109:511-2.
27. Holmes GP, Kaplan JE, Schonberger LB, Straus SE, Zegans LS, Gantz NM, et al. Definition of the chronic fatigue syndrome (Letter). Ann Intern Med. 1988; 109:512.
28. Hickie I, Lloyd A, Hadzi-Pavlovic D, Parker G, Bird K, Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med. (In press.).
29. Gunn WJ, Connell DB, Randall B. Epidemiology of chronic fatigue syndrome: the Centers for Disease Control study. In: Bock G, Whelan J, eds. Chronic Fatigue Syndrome. New York: Wiley; 1993:83-101. (Ciba Foundation symposium 173).
30. Lane TJ, Matthews DA, Manu P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci. 1990; 299:313-8.
31. Kroenke K. Chronic fatigue: frequency, causes, evaluation, and management. Compr Ther. 1989; 15:3-7.
32. Kuczmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr. 1992; 55(2 Suppl):495S-502S.
33. Bray GA. Pathophysiology of obesity. Am J Clin Nutr. 1992; 55(2 Suppl):488S-94S.
34. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988; 45:1069-77.
35. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry. 1981; 38:381-9.
36. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992; 49:624-9.
37. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993; 37:753-62.
38. Piper BF, Lindsey AM, Dodd MJ, Perketich S, Paul SM, Weller S. The development of an instrument to measure the subjective dimension of fatigue. In: Funk SG, Tournquist PM, Campagne MT, Archer Gopp L, Wiese RA, eds. Key Aspects of Comfort. Management of Pain, Fatigue and Nausea. New York: Springer; 1989:199-208.
39. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989; 46:1121-3.
40. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993; 37:147-53.
41. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994; 38:383-92.
42. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473-83.[Medline]
43. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981; XIX:787-805.
44. Katon W, Russo J. Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch Intern Med. 1992; 152:1604-9.
45. Lewis G, Wessely S. The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health. 1992; 46:92-7.
46. Barofsky I, Legro MW. Definition and measurement of fatigue. Rev Infect Dis. 1991; 13(Suppl 1):S94-7.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J. R. SHEEDY, R. E.H. WETTENHALL, D. SCANLON, P. R. GOOLEY, D. P. LEWIS, N. MCGREGOR, D. I. STAPLETON, H. L. BUTT, and K. L. DE MEIRLEIR Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome In Vivo, July 1, 2009; 23(4): 621 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Z. Katz, Y. Shiraishi, C. J. Mears, H. J. Binns, and R. Taylor Chronic Fatigue Syndrome After Infectious Mononucleosis in Adolescents Pediatrics, July 1, 2009; 124(1): 189 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Bakker, E. M. van de Putte, W. Kuis, and G. Sinnema Risk Factors for Persistent Fatigue With Significant School Absence in Children and Adolescents Pediatrics, July 1, 2009; 124(1): e89 - e95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M. Nater, J.-M. S. Lin, E. M. Maloney, J. F. Jones, H. Tian, R. S. Boneva, C. L. Raison, W. C. Reeves, and C. Heim Psychiatric Comorbidity in Persons With Chronic Fatigue Syndrome Identified From the Georgia Population Psychosom Med, June 1, 2009; 71(5): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Maloney, R. Boneva, U. M. Nater, and W. C. Reeves Chronic Fatigue Syndrome and High Allostatic Load: Results From a Population-Based Case-Control Study in Georgia Psychosom Med, June 1, 2009; 71(5): 549 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Graham and K. M Ritchie Postural orthostatic tachycardia syndrome BMJ Case Reports, April 19, 2009; 2009(apr19_1): bcr1020081132 - bcr1020081132. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Dinos, B. Khoshaba, D. Ashby, P. D White, J. Nazroo, S. Wessely, and K. S Bhui A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping Int. J. Epidemiol., April 6, 2009; (2009) dyp147v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Newton, A. Sheth, J. Shin, J. Pairman, K. Wilton, J. A. Burt, and D. E. J. Jones Lower Ambulatory Blood Pressure in Chronic Fatigue Syndrome Psychosom Med, April 1, 2009; 71(3): 361 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Alexander, O. Minton, and P. C. Stone Evaluation of Screening Instruments for Cancer-Related Fatigue Syndrome in Breast Cancer Survivors J. Clin. Oncol., March 10, 2009; 27(8): 1197 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Van Campen, F. Van Den Eede, G. Moorkens, C. Schotte, R. Schacht, B. G.C. Sabbe, P. Cosyns, and S. J. Claes Use of the Temperament and Character Inventory (TCI) for Assessment of Personality in Chronic Fatigue Syndrome Psychosomatics, March 1, 2009; 50(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. FREMONT, K. METZGER, H. RADY, J. HULSTAERT, and K. DE MEIRLEIR Detection of Herpesviruses and Parvovirus B19 in Gastric and Intestinal Mucosa of Chronic Fatigue Syndrome Patients In Vivo, March 1, 2009; 23(2): 209 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Repping-Wuts, P. van Riel, and T. van Achterberg Fatigue in patients with rheumatoid arthritis: what is known and what is needed Rheumatology, March 1, 2009; 48(3): 207 - 209. [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Cho, P. R. Menezes, M. Hotopf, D. Bhugra, and S. Wessely Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition The British Journal of Psychiatry, February 1, 2009; 194(2): 117 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cao, Y. Zhang, D. F. Chang, G. Wang, and X. Zhang Psychosocial and Immunological Factors in Neurasthenia Psychosomatics, January 1, 2009; 50(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Heim, U. M. Nater, E. Maloney, R. Boneva, J. F. Jones, and W. C. Reeves Childhood Trauma and Risk for Chronic Fatigue Syndrome: Association With Neuroendocrine Dysfunction Arch Gen Psychiatry, January 1, 2009; 66(1): 72 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hoad, G. Spickett, J. Elliott, and J. Newton Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome QJM, December 1, 2008; 101(12): 961 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. van de Putte, K. B. Bocker, J. Buitelaar, J. L. Kenemans, R. H. H. Engelbert, W. Kuis, J. L. L. Kimpen, and C. S. P. M. Uiterwaal Deficits of Interference Control in Adolescents With Chronic Fatigue Syndrome Arch Pediatr Adolesc Med, December 1, 2008; 162(12): 1196 - 1197. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fuller-Thomson and J. Nimigon Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey Fam. Pract., December 1, 2008; 25(6): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Van Houdenhove and P. Luyten Customizing Treatment of Chronic Fatigue Syndrome and Fibromyalgia: The Role of Perpetuating Factors Psychosomatics, November 1, 2008; 49(6): 470 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Knoop, J. W. M. van der Meer, and G. Bleijenberg Guided self-instructions for people with chronic fatigue syndrome: randomised controlled trial The British Journal of Psychiatry, October 1, 2008; 193(4): 340 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Majer, L. A. M. Welberg, L. Capuron, A. H. Miller, G. Pagnoni, and W. C. Reeves Neuropsychological Performance in Persons With Chronic Fatigue Syndrome: Results From a Population-Based Study Psychosom Med, September 1, 2008; 70(7): 829 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. P. de Lange, A. Koers, J. S. Kalkman, G. Bleijenberg, P. Hagoort, J. W. M. van der Meer, and I. Toni Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome Brain, August 1, 2008; 131(8): 2172 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Cheng, B. J. Gurland, and M. S. Maurer Self-Reported Lack of Energy (Anergia) Among Elders in a Multiethnic Community J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2008; 63(7): 707 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Chew-Graham, G. Cahill, C. Dowrick, A. Wearden, and S. Peters Using Multiple Sources of Knowledge to Reach Clinical Understanding of Chronic Fatigue Syndrome Ann. Fam. Med, July 1, 2008; 6(4): 340 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Kerr, B Burke, R Petty, J Gough, D Fear, D L Mattey, J S Axford, A G Dalgleish, and D J Nutt Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes J. Clin. Pathol., June 1, 2008; 61(6): 730 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kishi, Z. R. Struzik, B. H. Natelson, F. Togo, and Y. Yamamoto Dynamics of sleep stage transitions in healthy humans and patients with chronic fatigue syndrome Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1980 - R1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nelesen, Y. Dar, K. Thomas, and J. E. Dimsdale The Relationship Between Fatigue and Cardiac Functioning Arch Intern Med, May 12, 2008; 168(9): 943 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Arnold Understanding Fatigue in Major Depressive Disorder and Other Medical Disorders Psychosomatics, May 1, 2008; 49(3): 185 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Geisser, C. Strader Donnell, F. Petzke, R. H. Gracely, D. J. Clauw, and D. A. Williams Comorbid Somatic Symptoms and Functional Status in Patients With Fibromyalgia and Chronic Fatigue Syndrome: Sensory Amplification as a Common Mechanism Psychosomatics, May 1, 2008; 49(3): 235 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nijs, F. Almond, P. De Becker, S. Truijen, and L. Paul Can exercise limits prevent post-exertional malaise in chronic fatigue syndrome? An uncontrolled clinical trial Clinical Rehabilitation, May 1, 2008; 22(5): 426 - 435. [Abstract] [PDF]
|
|
|
|
 |
|
 D. S. Ciccone, L. Weissman, and B. H. Natelson Chronic Fatigue Syndrome in Male Gulf War Veterans and Civilians: A Further Test of the Single Syndrome Hypothesis J Health Psychol, May 1, 2008; 13(4): 529 - 536. [Abstract] [PDF]
|
|
|
|
|
|
R. M. Viner, C. Clark, S. J. C. Taylor, K. Bhui, E. Klineberg, J. Head, R. Booy, and S. A. Stansfeld Longitudinal Risk Factors for Persistent Fatigue in Adolescents Arch Pediatr Adolesc Med, May 1, 2008; 162(5): 469 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Harvey, M. Wadsworth, S. Wessely, and M. Hotopf Etiology of Chronic Fatigue Syndrome: Testing Popular Hypotheses Using a National Birth Cohort Study Psychosom Med, May 1, 2008; 70(4): 488 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S H Beqaj, A M Lerner, and J T Fitzgerald Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome J. Clin. Pathol., May 1, 2008; 61(5): 623 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Davies and E Crawley Chronic fatigue syndrome in children aged 11 years old and younger Arch. Dis. Child., May 1, 2008; 93(5): 419 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Unsworth, S. Graves, C. Nguyen, G. Kemp, J. Graham, and J. Stenos Markers of exposure to spotted fever rickettsiae in patients with chronic illness, including fatigue, in two Australian populations QJM, April 1, 2008; 101(4): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. M. Nater, L. S. Youngblood, J. F. Jones, E. R. Unger, A. H. Miller, W. C. Reeves, and C. Heim Alterations in Diurnal Salivary Cortisol Rhythm in a Population-Based Sample of Cases With Chronic Fatigue Syndrome Psychosom Med, April 1, 2008; 70(3): 298 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M. Nater, E. Maloney, R. S. Boneva, B. M. Gurbaxani, J.-M. Lin, J. F. Jones, W. C. Reeves, and C. Heim Attenuated Morning Salivary Cortisol Concentrations in a Population-Based Study of Persons with Chronic Fatigue Syndrome and Well Controls J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 703 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stubhaug, S. A. Lie, H. Ursin, and H. R. Eriksen Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial The British Journal of Psychiatry, March 1, 2008; 192(3): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. ter Wolbeek, L. J. P. van Doornen, A. Kavelaars, and C. J. Heijnen Predictors of Persistent and New-onset Fatigue in Adolescent Girls Pediatrics, March 1, 2008; 121(3): e449 - e457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Knoop, M. Stulemeijer, L. W. A. M. de Jong, T. J. W. Fiselier, and G. Bleijenberg Efficacy of Cognitive Behavioral Therapy for Adolescents With Chronic Fatigue Syndrome: Long-term Follow-up of a Randomized, Controlled Trial Pediatrics, March 1, 2008; 121(3): e619 - e625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chen, J. Moriya, J.-i. Yamakawa, T. Takahashi, and T. Kanda Traditional Chinese Medicine for Chronic Fatigue Syndrome Evid. Based Complement. Altern. Med., February 27, 2008; (2008) nen017v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lim, K. S. Thomas, W. A. Bardwell, and J. E. Dimsdale Which Measures of Obesity Are Related to Depressive Symptoms and in Whom? Psychosomatics, February 1, 2008; 49(1): 23 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R Kerr Enterovirus infection of the stomach in chronic fatigue syndrome/myalgic encephalomyelitis J. Clin. Pathol., January 1, 2008; 61(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
B. Van Houdenhove, L. Verheyen, K. Pardaens, P. Luyten, and P. Van Wambeke Rehabilitation of decreased motor performance in patients with chronic fatigue syndrome: should we treat low effort capacity or reduced effort tolerance? Clinical Rehabilitation, December 1, 2007; 21(12): 1121 - 1142. [Abstract] [PDF]
|
|
|
|
|
|
D. Z. Kuo, T. L. Cheng, and P. C. Rowe Successful Use of a Primary Care Practice Specialty Collaboration in the Care of an Adolescent With Chronic Fatigue Syndrome Pediatrics, December 1, 2007; 120(6): e1536 - e1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. A. Kanaan, J. P. Lepine, and S. C. Wessely The Association or Otherwise of the Functional Somatic Syndromes Psychosom Med, November 1, 2007; 69(9): 855 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Daly and A. J. Hartz Perspectives of Family Medicine Physicians and Licensed Acupuncture Clinicians on Caring for Persons With Unexplained Chronic Fatigue Complementary Health Practice Review, October 1, 2007; 12(3): 196 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Niblett, K. E. King, R. H. Dunstan, P. Clifton-Bligh, L. A. Hoskin, T. K. Roberts, G. R. Fulcher, N. R. McGregor, J. C. Dunsmore, H. L. Butt, et al. Hematologic and Urinary Excretion Anomalies in Patients with Chronic Fatigue Syndrome Experimental Biology and Medicine, September 1, 2007; 232(8): 1041 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.L. Newton, O. Okonkwo, K. Sutcliffe, A. Seth, J. Shin, and D.E.J. Jones Symptoms of autonomic dysfunction in chronic fatigue syndrome QJM, August 1, 2007; 100(8): 519 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Crofford Violence, Stress, and Somatic Syndromes Trauma Violence Abuse, July 1, 2007; 8(3): 299 - 313. [Abstract] [PDF]
|
|
|
|
|
|
V. B. Wyller, K. Godang, L. Morkrid, J. P. Saul, E. Thaulow, and L. Walloe Abnormal Thermoregulatory Responses in Adolescents With Chronic Fatigue Syndrome: Relation to Clinical Symptoms Pediatrics, July 1, 2007; 120(1): e129 - e137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A K Agarwal, R Garg, A Ritch, and P Sarkar Postural orthostatic tachycardia syndrome Postgrad. Med. J., July 1, 2007; 83(981): 478 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. C. Njoku, L. A. Jason, and S. R. Torres-Harding The Prevalence of Chronic Fatigue Syndrome in Nigeria J Health Psychol, May 1, 2007; 12(3): 461 - 474. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Vervoort, G. Crombez, A. Buysse, L. Goubert, T. D. Backer, and W. Ickes Brief Report: The Accuracy of Parents for the Thoughts and Feelings of Their Adolescent Suffering from Chronic Fatigue: A Preliminary Study of Empathy J. Pediatr. Psychol., May 1, 2007; 32(4): 494 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Knoop, J. B Prins, M. Stulemeijer, J. W M van der Meer, and G. Bleijenberg The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 434 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Edwards, A. R. Thompson, and A. Blair An 'Overwhelming Illness': Women's Experiences of Learning to Live with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis J Health Psychol, March 1, 2007; 12(2): 203 - 214. [Abstract] [PDF]
|
|
|
|
|
|
K. A. Rimes, R. Goodman, M. Hotopf, S. Wessely, H. Meltzer, and T. Chalder Incidence, Prognosis, and Risk Factors for Fatigue and Chronic Fatigue Syndrome in Adolescents: A Prospective Community Study Pediatrics, March 1, 2007; 119(3): e603 - e609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ryall, D. Coggon, R. Peveler, J. Poole, and K. T. Palmer A prospective cohort study of arm pain in primary care and physiotherapy--prognostic determinants Rheumatology, March 1, 2007; 46(3): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Grans, M. Nilsson, K. Dahlman-Wright, and B. Evengard Reduced levels of oestrogen receptor {beta} mRNA in Swedish patients with chronic fatigue syndrome J. Clin. Pathol., February 1, 2007; 60(2): 195 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J R Kerr, P Christian, A Hodgetts, P R Langford, L D Devanur, R Petty, B Burke, L I Sinclair, S C M Richards, J Montgomery, et al. Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments J. Clin. Pathol., February 1, 2007; 60(2): 113 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B M Carruthers Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works J. Clin. Pathol., February 1, 2007; 60(2): 117 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Guise, S. Widdicombe, and A. McKinlay 'What is it like to have ME?': The discursive construction of ME in computer-mediated communication and face-to-face interaction Health (London) , January 1, 2007; 11(1): 87 - 108. [Abstract] [PDF]
|
|
|
|
|
|
F. Friedberg and J. Quick Alexithymia in Chronic Fatigue Syndrome: Associations With Momentary, Recall, and Retrospective Measures of Somatic Complaints and Emotions Psychosom Med, January 1, 2007; 69(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Heim, D. Wagner, E. Maloney, D. A. Papanicolaou, L. Solomon, J. F. Jones, E. R. Unger, and W. C. Reeves Early Adverse Experience and Risk for Chronic Fatigue Syndrome: Results From a Population-Based Study. Arch Gen Psychiatry, November 1, 2006; 63(11): 1258 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kato, P. F. Sullivan, B. Evengard, and N. L. Pedersen Premorbid predictors of chronic fatigue. Arch Gen Psychiatry, November 1, 2006; 63(11): 1267 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Caseras, D. Mataix-Cols, V. Giampietro, K. A. Rimes, M. Brammer, F. Zelaya, T. Chalder, and E. L. Godfrey Probing the Working Memory System in Chronic Fatigue Syndrome: A Functional Magnetic Resonance Imaging Study Using the n-Back Task Psychosom Med, November 1, 2006; 68(6): 947 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chambers, A.-M. Bagnall, S. Hempel, and C. Forbes Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med, October 1, 2006; 99(10): 506 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E M van de Putte, R H H Engelbert, W Kuis, J L L Kimpen, and C S P M Uiterwaal How fatigue is related to other somatic symptoms Arch. Dis. Child., October 1, 2006; 91(10): 824 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hickie, T. Davenport, D. Wakefield, U. Vollmer-Conna, B. Cameron, S. D Vernon, W. C Reeves, A. Lloyd, and Dubbo Infection Outcomes Study Group Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study BMJ, September 16, 2006; 333(7568): 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Hyland, S. C. Sodergren, and G. T. Lewith Chronic Fatigue Syndrome: The Role of Positivity to Illness in Chronic Fatigue Syndrome Patients J Health Psychol, September 1, 2006; 11(5): 731 - 741. [Abstract] [PDF]
|
|
|
|
|
|
T. A. Fowler, F. Rice, A. Thapar, and A. Farmer Relationship between disabling fatigue and depression in children: Genetic study The British Journal of Psychiatry, September 1, 2006; 189(3): 247 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kato, P. F. Sullivan, B. Evengard, and N. L. Pedersen Chronic Widespread Pain and Its Comorbidities: A Population-Based Study. Arch Intern Med, August 14, 2006; 166(15): 1649 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J H Huibers, S S Leone, I. Kant, and J A Knottnerus Chronic fatigue syndrome-like caseness as a predictor of work status in fatigued employees on sick leave: four year follow up study Occup. Environ. Med., August 1, 2006; 63(8): 570 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Jerjes, N. F. Taylor, T. J. Peters, S. Wessely, and A. J. Cleare Urinary Cortisol and Cortisol Metabolite Excretion in Chronic Fatigue Syndrome Psychosom Med, July 1, 2006; 68(4): 578 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. McDermott, S.C.M. Richards, P.W. Thomas, J. Montgomery, and G. Lewith A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome QJM, July 1, 2006; 99(7): 461 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. B. Axelrod, G. G. Chelimsky, and D. E. Weese-Mayer Pediatric Autonomic Disorders Pediatrics, July 1, 2006; 118(1): 309 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Wearden and C. Chew-Graham Managing chronic fatigue syndrome in UK primary care: challenges and opportunities Chronic Illness, June 1, 2006; 2(2): 143 - 153. [Abstract] [PDF]
|
|
|
|
|
|
E. M. van de Putte, L. J. P. van Doornen, R. H. H. Engelbert, W. Kuis, J. L. L. Kimpen, and C. S. P. M. Uiterwaal Mirrored Symptoms in Mother and Child With Chronic Fatigue Syndrome. Pediatrics, June 1, 2006; 117(6): 2074 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. ter Wolbeek, L. J.P. van Doornen, A. Kavelaars, and C. J. Heijnen Severe fatigue in adolescents: a common phenomenon? Pediatrics, June 1, 2006; 117(6): e1078 - e1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Moss-Morris and M. Spence To "Lump" or to "Split" the Functional Somatic Syndromes: Can Infectious and Emotional Risk Factors Differentiate Between the Onset of Chronic Fatigue Syndrome and Irritable Bowel Syndrome? Psychosom Med, May 1, 2006; 68(3): 463 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ismail and G. Lewis Multi-symptom illnesses, unexplained illness and Gulf War Syndrome Phil Trans R Soc B, April 29, 2006; 361(1468): 543 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sim and H. Kelsall Gulf War illness: a view from Australia Phil Trans R Soc B, April 29, 2006; 361(1468): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C Glass and M. R Sim The challenges of exposure assessment in health studies of Gulf War veterans Phil Trans R Soc B, April 29, 2006; 361(1468): 627 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sharpe The symptom of generalised fatigue Practical Neurology, April 1, 2006; 6(2): 72 - 77. [Full Text] [PDF]
|
|
|
|
|
|
V. R Aggarwal, J. McBeth, J. M Zakrzewska, M. Lunt, and G. J Macfarlane The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int. J. Epidemiol., April 1, 2006; 35(2): 468 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Salamon, C Verret, M A Jutand, M Begassat, F Laoudj, F Conso, and P Brochard Health consequences of the first Persian Gulf War on French troops Int. J. Epidemiol., April 1, 2006; 35(2): 479 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cornuz, I. Guessous, and B. Favrat Fatigue: a practical approach to diagnosis in primary care. Can. Med. Assoc. J., March 14, 2006; 174(6): 765 - 767. [Full Text] [PDF]
|
|
|
|
|
|
T. Takahashi, F. Yu, S.-j. Zhu, J. Moriya, H. Sumino, S. Morimoto, N. Yamaguchi, and T. Kanda Beneficial effect of brewers' yeast extract on daily activity in a murine model of chronic fatigue syndrome. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 109 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ryall, D. Coggon, R. Peveler, I. Reading, and K. T. Palmer A case-control study of risk factors for arm pain presenting to primary care services Occup. Med., March 1, 2006; 56(2): 137 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Pardaens, L Haagdorens, P Van Wambeke, A Van den Broeck, and B Van Houdenhove How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study Clinical Rehabilitation, January 1, 2006; 20(1): 56 - 66. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Sankey, C. M. Hill, J. Brown, L. Quinn, and A. Fletcher A Follow-up Study of Chronic Fatigue Syndrome in Children and Adolescents: Symptom Persistence and School Absenteeism Clinical Child Psychology and Psychiatry, January 1, 2006; 11(1): 126 - 138. [Abstract] [PDF]
|
|
|
|
 |
|
 D. C. Randall, F. H. Cafferty, J. M. Shneerson, I. E. Smith, M. B. Llewelyn, and S. E. File Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome J Psychopharmacol, November 1, 2005; 19(6): 647 - 660. [Abstract] [PDF]
|
|
Read all Rapid Responses
